The Role of ADAM-15 Disintegrin in E-cadherin Proteolysis in Prostate Cancer Metastasis
Abstract
The primary goal of this proposal was to demonstrate that the membrane disintegrin, ADAM-15, could E-cadherin in prostate cancer cells, and that in this regard ADAM-15 would promote the metastatic growth of prostate cancer. The successful completion of this study has led to the confirmation of the functional role of ADAM15 in the cleavage of E-cadherin and metastatic growth of prostate cancer cells. These results justify continuing studies examining the metalloproteinase domain of ADAM15 as a direct therapeutic target for metastatic prostate cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2008
- Accession Number
- ADA491608
Entities
People
- Mark L. Day
Organizations
- University of Michigan